Showing 1 - 1 results of 1 for search 'Brescia C', query time: 0.02s Refine Results
  1. 1
    Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study

    Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study by Megna M, Ruggiero A, Tommasino N, Brescia C, Martora F, Cacciapuoti S, Potestio L

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: